All In Biotech

Drug Trial Radar · NCT05047601

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF 07321332/RITONAVIR IN PREVENTING SYMPTOMATIC SARS-COV-2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF AN INDIVIDUAL WITH SYMPTOMATIC COVID-19

Last checked: Nov 20, 2026Latest source record: May 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,954 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,954

Actual

Start

Sep 9, 2021

Primary completion

Apr 12, 2022

Study completion Apr 12, 2022

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Sep 17, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical trial is to learn whether the study medicine prevent symptoms of COVID-19 in adults who have been exposed to household member(s) with a confirmed symptomatic COVID-19 infection. All participants in the study will receive treatment for COVID-19 as needed, based on their regular doctor's recommendation. Two-thirds of participants will also receive two study medicines (PF-07321332 and ritonavir) by mouth twice a day for either five or ten days. We will compare the experiences of people receiving the study medicines to those of the people who do not. This will help us determine if the study medicines are safe and effective

Conditions

  • COVID-19

Interventions

  • PF-07321332Drug

    PF-07321332

  • Placebo for PF-07321332Drug

    Placebo

  • Placebo for RitonavirDrug

    Placebo

  • RitonavirDrug

    Ritonavir

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Developed Symptomatic RT-PCR or RAT Confirmed SARS-CoV-2 Infection Through Day 14: Among Participants With Negative RT-PCR at BaselineTime frame: From Day 1 to Day 14

Locations

170 sites in 17 countries. Site status is shown where the registry gives one.

  • Cahaba Research Inc

    Pelham, Alabama

  • The Institute for Liver Health dba Arizona Clinical Trials

    Tucson, Arizona

  • Ascada Health PC

    Fullerton, California

  • Optimus Medical Group

    San Francisco, California

  • Synergy Healthcare

    Bradenton, Florida

  • MOORE Clinical Research, Inc.

    Brandon, Florida

  • TrueBlue Clinical Research

    Brandon, Florida

  • Herco Medical and Research Center Inc

    Coral Gables, Florida

  • Advance Clinical Research Group

    Cutler Bay, Florida

  • Beautiful Minds Clinical Research Center

    Cutler Bay, Florida

  • Qway Research

    Hialeah, Florida

  • Eastern Research Inc

    Hialeah, Florida

  • Inpatient Research Clinic

    Hialeah, Florida

  • Doral Medical Research,LLC

    Hialeah, Florida

  • Unlimited Medical Research Group, LLC

    Hialeah Gardens, Florida

  • ASCLEPES Research Centers

    Lutz, Florida

  • Angels Clinical Research Institute

    Miami, Florida

  • LCC Medical Research Institute, LLC

    Miami, Florida

  • Premium Medical Research Corp

    Miami, Florida

  • Global Health Clinical Trials Corp

    Miami, Florida

  • South Florida Research Center, Inc.

    Miami, Florida

  • University of Miami Health System

    Miami, Florida

  • I.V.A.M. Clinical & Investigational Center, LLC

    Miami, Florida

  • Medical Research of Westchester Inc

    Miami, Florida

  • C'A Research

    Miami, Florida

  • ProLive Medical Research, Corp.

    Miami, Florida

  • Entrust Clinical Research

    Miami, Florida

  • Reed Medical Research

    Miami, Florida

  • Kendall South Medical Center, Inc.

    Miami, Florida

  • Clinical Site Partners, Inc dba CSP Miami

    Miami, Florida

  • Coral Research Clinic Corp

    Miami, Florida

  • Pro-Care Research Center, Corp.

    Miami Gardens, Florida

  • Savin Medical Group, LLC

    Miami Lakes, Florida

  • Omega Research Orlando

    Orlando, Florida

  • NAPA Research LLC

    Pompano Beach, Florida

  • CDC Research Institute, LLC

    Port Saint Lucie, Florida

  • USPA Advance Concept Medical Research Group LLC

    South Miami, Florida

  • ASCLEPES Research Centers

    Spring Hill, Florida

  • GCP, Global Clinical Professionals

    St. Petersburg, Florida

  • Sunrise Research Institute

    Sunrise, Florida

Showing 40 of 170 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.